Introduction
Thiazide diuretics have been recommended by international guidelines as first-line agents in the management of hypertension, including the seventh report of the Joint National Committee 1 and the National Institute of Clinical Excellence 2 . However, thiazide diuretics could induce metabolic side effects including hyponatremia and hypokalemia 3, 4 , and the majority of patients admitted to hospitals due to electrolyte disturbances can be attributed to diuretic use 5 . This has recently been shown to deter physicians from prescribing thiazides to Chinese patients 6 .
The majority of these reports were conducted in Caucasian countries and electrolyte profiles among Chinese hypertensive patients on thiazides have been scarce and smallscaled 7 . Ethnicity is associated with different pharmacological outcomes of antihypertensive agents and even small ethnic differences may bear substantial health resource implications 8 .
The present study examined the effect of antihypertensive drug classes on hyponatremia/ hypokalemia among ethnic Chinese, and evaluated the associated factors of these electrolyte disturbances. We tested the hypothesis that the likelihood of hyponatremia and hypokalemia after antihypertensive prescriptions were similar among patients prescribed major antihypertensive classes.
4
Methods

Data source
The Clinical Data Analysis and Reporting System (CDARS) of the Hospital Authority,
Hong Kong consists of all patient records in public clinic visits since 2000. It captures patients' demographics, clinical information including diagnoses, prescription details and laboratory investigation results in every out-patient consultation. One of the major functions of CDARS is research 9 . It is the single portal of information entry in the public sector, and is a comprehensive record which allows cross-referencing when patients visit a different clinic. Also, drug prescription details are doubly checked by pharmacist professionals and any amendments were recorded in the electronic patient record. In addition to these good practices this database has been evaluated and found to have a high level of completeness with respect to demographic data (100%) and prescription details (99.98%) 10 . Box 1) . Also, patients discontinued or switched their drug prescription or received sodium or potassium supplements before electrolyte measurements were excluded. In addition, medication adherence was assessed by evidence that the patients attended for medication refill at a consultation time where their drug stocks would expire. We calculated the Medication Possession Ratio (MPR) for each patient, defined as the ratio of total days of medication supplied (not including the last prescription) to total days in a period of time 12 . Those with MPR < 0.8 were considered drug non-compliant and excluded 12 . The minimum follow-up time was 4 weeks in all the eligible cases as indicated by our database.
Each patient was classified into one drug group according to the prescription. These include β-blockers (BBs), thiazide diuretics, Calcium Channel Blockers (CCBs), drugs acting on the renin angiotensin system (RAS) and others (including α-blockers, potassium-sparing and other diuretics, vasodilators and combination therapy). We 6 evaluated the dosage of each prescription qualitatively as "low", "medium" or "high" according to standard drug formulary.
Outcomes Variables, associated factors and statistical analysis
We evaluated the mean plasma Na/K levels and proportions of patients having low (Na < 135 mEq/L; K < 3.4 mEq/L), normal (Na 136-147 mEq/L; K 3. where district of residence was included and then excluded as an independent variable, respectively, to avoid over-controlling of covariates. All p<0.05 were regarded as statistically significant.
Results
We included 2,759 eligible patient records, with a mean age of 63.6 years (95% C.I. 63.4, 64.5) ( Table 1 ). The CCB group was the eldest and had the highest proportion of male patients and the BB group was the youngest and had the lowest proportion of male patients. Their electrolyte levels were measured approximately 8 weeks after prescriptions and these periods were statistically similar among antihypertensive drug classes (p=0.06). From the drug formulary we judged that > 90% of antihypertensive prescriptions were of standard dosage (i.e. medium dose), and the proportion of prescription dosage being medium when the major drug classes were compared showed no significant differences (p=0.42) ( Table 2) . Unreliable sodium and potassium levels were reported in 85 and 126 patients respectively due to lipemic or hemolytic blood samples. For all patients, the mean sodium and potassium levels were 140.0 mEq/L (95% C.I. 139.9, 140.1) and 3.99 mEq/L (95% C.I. 3.97, 4.01) respectively. Among the four major antihypertensive drug classes, thiazide users had the lowest sodium levels, whereas CCB and thiazide had the lowest potassium levels. Users of β-blockers and RAS had higher GFR than other drug classes (p<0.001) ( Table 2 ). Only one patient had hypernatremia, and the proportion of patients having abnormal sodium and potassium levels were both low (3.9% and 10.6% respectively, Table 2 ).
We compared the clinical characteristics of patients having hyponatremia or hypokalemia with patients with normonatremia and normokalemia respectively. Hyponatremic patients and hypokalemic patients were significantly older than normonatremic and normokalemic patients, respectively ( Table 3) . Comparison between hyponatremic or hypokalemic patients with normonatremic and normokalemic patients respectively according to gender, payment status, district of residence and service types of clinics were all statistically insignificant. Among all drug classes, thiazide users had higher proportions of hyponatremia than normonatremic patients, while CCB and thiazide users had higher proportions of hypokalemia than normokalemic patients ( Table 3) . When divided into tertiles, the estimated GFR among hyponatremic patients was significantly lower than normonatremic patients (p<0.001) whereas no difference in GFR was reported between hypokalemic and normokalemic patients (p=0.10) ( Table 3) .
Two separate, unconditional binary logistic regression analyzes were performed with hyponatremia and hypokalemia as outcome variables, respectively, to evaluate the factors related to these electrolyte disturbances. When controlled for covariates, advanced age (> 70 years) was associated with hyponatremia when compared with patients < 50 years (Table 4) . Male patients had significantly higher odds of hyponatremia than females.
Residence in the North district (the most rural region) was negatively associated with hyponatremia or hypokalemia. Patients with the highest GFR (3 rd tertile) were significantly less likely to have hyponatremia. Thiazide users were positively associated with hyponatremia; users of RAS and β-blockers were negatively associated with hypokalemia. When district of residence was excluded from the regression analyses, the findings remained similar.
Discussion
Major findings
This study showed that thiazide diuretics had the lowest levels of plasma sodium, while CCBs and thiazide diuretics had the lowest levels of plasma potassium approximately 8
weeks after the first-ever antihypertensive prescription when compared to other drug classes, but the absolute magnitude of differences were minimal. From multivariate analyzes advanced age, male gender and thizide user were positively associated with hyponatremia, while RAS and β-blockers were less likely to present with hypokalemia when compared with CCB. However, the proportions of patients having these electrolyte disturbances were not high.
Interpretation and relationship with literatures
A previous study in UK general practices reported a higher proportion of hyponatremia (13.7%) and hypokalemia (8.5%) among thiazide users 14 . The same study also reported that increased age (> 70 years) was significantly associated with hyponatremia, and that hypokalemia was associated with thiazide use. In ethnic groups other than Chinese, thiazides have been shown to cause hypokalemia, and potassium levels have been shown to be linearly correlated with blood pressure levels 15 . Another study in the US has identified a positive association between thiazide use and symptomatic hyponatremia requiring hospital admission 16 . Among Chinese patients, there is one study evaluating prescriptions of diuretics in two out-patient clinics and concluded that diuretic use was associated with hypokalemia 17 . This study demonstrated that advanced age was independently related to hyponatremia. It has been recognized that elderly women could 11 have expanded fluid volume after increased fluid intake but decreased ability to excrete free water, which might explain the higher risks of hyponatremia among the elderly 18 .
It is unknown why male patients and residents in rural districts had significantly different odds of presenting with these electrolyte disturbances from published literatures, where the underlying reasons remained to be explored.
In addition, the proportion of hyponatremic in hypokalemic patients (15.5%) was greater than normonatremic patients (9.1%) (p=0.02), highlighting this as a possible moderator of medication effect. It is consistent with the fact that potassium depletion causes a water shift from the intracellular space to the extracellular space and exchangeable potassium is hence a determinant of serum Na concentration.
Also, despite the lowest sodium level among thiazide users and lowest potassium levels among CCB users, and that multivariate regression analyzes showed that some drug classes were significantly associated with hyponatremia/hypokalemia, these absolute differences with the mean sodium and potassium values of all patients, respectively, were minimal (0.4 mEq/L and 0.07 mEq/L respectively). Since we included a large sample from the whole Territory our results may be more representative of hypertensive patients than previous studies. In addition, the inclusion of antihypertensive drug naïve patients with uncomplicated hypertension only without concomitant cardiovascular factors; drug regimen changes; or sodium and potassium supplements provides a relatively uncontaminated sample for evaluating the pharmacologic effects of antihypertensive agents. However, the lower potassium levels among CCB users remain unexplained by current published literatures, while on the contrary CCBs such as verapamil and nifedipine, at pharmacologic doses, have been proposed to block aldosterone production causing hyperkalemia rather than hypokalemia 19 . Nevertheless, we only studied electrolyte abnormalities 8 weeks after drug prescriptions and patients had uncomplicated hypertension only, therefore the applicability of these findings to patients with multi-comorbidities should be cautious.
Limitations of the present study
We have included Chinese patients in this study and it is well recognized that ethnicity is an important factor affecting the pharmacologic actions of antihypertensive drugs 8 , hence these findings might not be generalizable to patients of other races. In addition, baseline electrolyte levels were not available for comparison among drug classes. Furthermore, we evaluated risk-association but not cause-and-effect relationship, which should be more appropriately addressed by a prospective study. A more comprehensive evaluation should include dietary surveys on fruit and vegetable intake which had significant bearings on plasma electrolyte levels.
Implications to clinical practice
Translated into clinical practice, male patients with advanced age should have their sodium levels monitored more closely. Physicians should not be deterred from prescribing thiazide. Some caution however is needed in prescribing thiazide and CCBs since the prevalence of hypokalemia (11.8% and 12.8% respectively) is still not negligible, especially when hypokalemia also causes resistant hypertension and can induce salt sensitivity. Similar studies comparing the odds of dyslipidemia and impaired fasting glucose from users of antihypertensive prescriptions reported no significant differences among antihypertensive drug classes [20] [21] . The present study adds further (CCB: Calcium Channel Blockers; RAS: drugs acting on the renin angiotensin system. We excluded 85 and 126 patients with sodium and potassium readings, respectively, regarded as unreliable due to lipemic or hemolyzed samples. The p values represent chi square tests among the first four antihypertensive drug classes across variables in that row *including α-blockers (65%), single pill with at least two antihypertensive drug component (33.8%), and miscellaneous (1.2%; potassium-sparing diuretics and vasodilators) **The estimated Glomerular Filtration Rate was derived from the Cockcroft-Gault formula (cOR: crude odds ratios; aOR: adjusted odds ratios; GFR Glomerular Filtration Rate; FMSC: Family Medicine Specialist Clinic; RAS: drugs acting on the renin angiotensin system; CCB: Calcium Channel Blockers. All the adjusted odds ratios were adjusted for Glomerular filtration rate and the variables listed in this table with hyponatremia and hypokalemia as outcome variables respectively. All the percentages were across rows. *The estimated Glomerular Filtration Rate was derived from the Cockcroft-Gault formula)
